[HTML][HTML] The long and short non-coding RNAs modulating EZH2 signaling in cancer

S Mirzaei, MH Gholami, K Hushmandi… - Journal of hematology & …, 2022 - Springer
Non-coding RNAs (ncRNAs) are a large family of RNA molecules with no capability in
encoding proteins. However, they participate in developmental and biological processes …

[HTML][HTML] Breast cancer metastasis: mechanisms and therapeutic implications

M Park, D Kim, S Ko, A Kim, K Mo, H Yoon - International journal of …, 2022 - mdpi.com
Breast cancer is the most common malignancy in women worldwide. Metastasis is the
leading cause of high mortality in most cancers. Although predicting the early stage of breast …

[HTML][HTML] Protein arginine methyltransferases: promising targets for cancer therapy

JW Hwang, Y Cho, GU Bae, SN Kim… - Experimental & molecular …, 2021 - nature.com
Protein methylation, a post-translational modification (PTM), is observed in a wide variety of
cell types from prokaryotes to eukaryotes. With recent and rapid advancements in epigenetic …

[HTML][HTML] Mechanisms of Polycomb group protein function in cancer

V Parreno, AM Martinez, G Cavalli - Cell Research, 2022 - nature.com
Cancer arises from a multitude of disorders resulting in loss of differentiation and a stem cell-
like phenotype characterized by uncontrolled growth. Polycomb Group (PcG) proteins are …

Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications

Q Zhong, X Xiao, Y Qiu, Z Xu, C Chen, B Chong… - MedComm, 2023 - Wiley Online Library
Protein posttranslational modifications (PTMs) refer to the breaking or generation of covalent
bonds on the backbones or amino acid side chains of proteins and expand the diversity of …

Pharmacological manipulation of Ezh2 with salvianolic acid B results in tumor vascular normalization and synergizes with cisplatin and T cell-mediated …

C Qian, C Yang, Y Tang, W Zheng, Y Zhou… - Pharmacological …, 2022 - Elsevier
Tumor vasculature is characterized by aberrant structure and function, resulting in immune
suppressive profiles of tumor microenvironment (TME) through limiting immune cell …

[HTML][HTML] PRMT2 promotes RCC tumorigenesis and metastasis via enhancing WNT5A transcriptional expression

Z Li, C Chen, H Yong, L Jiang, P Wang, S Meng… - Cell Death & …, 2023 - nature.com
Abstract Protein arginine methyltransferase 2 (PRMT2) is involved in several biological
processes via histone methylation and transcriptional regulation. Although PRMT2 has been …

[HTML][HTML] PRMT1-mediated EZH2 methylation promotes breast cancer cell proliferation and tumorigenesis

Z Li, D Wang, X Chen, W Wang, P Wang, P Hou… - Cell death & …, 2021 - nature.com
Abstract Protein arginine methyltransferase 1 (PRMT1) is able to promote breast cancer cell
proliferation. However, the detailed mechanisms of PRMT1-mediated breast cancer cell …

[HTML][HTML] PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6

Y Jia, X Yu, R Liu, L Shi, H Jin, D Yang, X Zhang… - Cell Death & …, 2023 - nature.com
Epigenetic modifications play important roles during the pathogenesis of multiple myeloma
(MM). Herein, we found that protein arginine methyltransferase 1 (PRMT1) was highly …

[HTML][HTML] Post-translational modifications of EZH2 in cancer

Z Li, M Li, D Wang, P Hou, X Chen, S Chu, D Chai… - Cell & bioscience, 2020 - Springer
Enhancer of zeste homolog 2 (EZH2), as a main component of Polycomb Repressive
Complex 2, catalyzes histone H3K27me3 to silence its target gene expression. EZH2 …